» Articles » PMID: 33747783

The Changing Face of Central Chondrosarcoma of Bone. One UK-based Orthopaedic Oncology Unit's Experience of 33 Years Referrals

Overview
Specialty Orthopedics
Date 2021 Mar 22
PMID 33747783
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To ascertain the changing incidence over time of the three commonest primary sarcomas of bone. Data obtained with particular reference to central chondrosarcoma from the annual referral rate to a large UK-based specialist orthopaedic oncology unit. To discuss how the "barnyard pen" analogy of cancers previously applied to certain commoner cancers can also be applicable to central chondrosarcoma (CS) of bone.

Materials And Methods: A retrospective review was conducted of a computerised database identifying all central cartilage tumours (CCT) of bone, including enchondroma and CS subtypes, between 1985 and 2018. These were compared with the referrals of the other two commonest primary sarcomas of bone, osteosarcoma and Ewing sarcoma.

Results: There was a total of 1507 CS showing a 68% overall increase in annual referral rate/incidence over the study period. 68% cases were the borderline malignant lesions now known as atypical cartilaginous tumour (ACT). The annual referral rate/incidence of this entity increased by 194% over the 30 years. Whereas, the annual referral rate/incidence for osteosarcoma and Ewing sarcoma was static for the past 20 years.

Conclusion: The annual incidence of central CS of bone showed a marked increase over the 33-year period as compared with both osteosarcoma and Ewing sarcoma. This is especially in the ACT category and is thought to be due to the increased provision of MRI scanning flagging up a rise in incidental findings. The spectrum of CCTs from benign to highly malignant elegantly fits the "barn yard" pen analogy and could prove useful as an explanatory tool for patients and clinicians unfamiliar with these diseases.

Citing Articles

Chondrosarcoma evaluation using hematein-based x-ray staining and high-resolution 3D micro-CT: a feasibility study.

Gersing A, Kimm M, Bollwein C, Ilg P, Mogler C, Gassert F Eur Radiol Exp. 2024; 8(1):58.

PMID: 38735899 PMC: 11089022. DOI: 10.1186/s41747-024-00454-0.


Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations.

Laitinen M, Thorkildsen J, Morris G, Kurisunkal V, Stevenson J, Parry M J Bone Oncol. 2023; 43:100514.

PMID: 38033413 PMC: 10682821. DOI: 10.1016/j.jbo.2023.100514.


Fracture risk after intralesional curettage of atypical cartilaginous tumors.

Krebbekx G, Fris F, Schaap G, Bramer J, Verspoor F, Janssen S J Orthop Surg Res. 2023; 18(1):851.

PMID: 37946306 PMC: 10634173. DOI: 10.1186/s13018-023-04215-4.


The Enigma of Atypical Cartilaginous Tumors: Surgery or Surveillance?.

Leithner A, Smolle M Cancers (Basel). 2023; 15(19).

PMID: 37835390 PMC: 10571963. DOI: 10.3390/cancers15194696.


[Primary malignant bone tumors].

Funovics P Orthopadie (Heidelb). 2023; 52(6):509-522.

PMID: 37278729 DOI: 10.1007/s00132-023-04387-1.


References
1.
HINMAN Jr F . Screening for prostatic carcinoma. J Urol. 1991; 145(1):126-9; discussion 129-30. DOI: 10.1016/s0022-5347(17)38267-8. View

2.
Hong E, Carrino J, Weber K, Fayad L . Prevalence of shoulder enchondromas on routine MR imaging. Clin Imaging. 2011; 35(5):378-84. DOI: 10.1016/j.clinimag.2010.10.012. View

3.
Walden M, Murphey M, Vidal J . Incidental enchondromas of the knee. AJR Am J Roentgenol. 2008; 190(6):1611-5. DOI: 10.2214/AJR.07.2796. View

4.
van Praag Veroniek V, Rueten-Budde A, Ho V, Dijkstra P, Fiocco M, van de Sande M . Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas. Surg Oncol. 2018; 27(3):402-408. DOI: 10.1016/j.suronc.2018.05.009. View

5.
Welch H, Fisher E . Income and Cancer Overdiagnosis - When Too Much Care Is Harmful. N Engl J Med. 2017; 376(23):2208-2209. DOI: 10.1056/NEJMp1615069. View